Stockreport

Soleno Therapeutics rallies on report of $2.5B Neurocrine buyout talks [Seeking Alpha]

Neurocrine Biosciences, Inc.  (NBIX) 
Last neurocrine biosciences, inc. earnings: 2/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: neurocrine.com/about-us/webcasts-presentations
PDF that Neurocrine Biosciences ( NBIX ) is in advanced talks to buy the biotech firm in a $2.5B-plus deal. The deal could value Soleno in the low-to-mid $50s Newsletter [Read more]